RUNX3 promoter methylation is associated with hepatocellular carcinoma risk: A meta-analysis

Cancer Investigation

Volumn 33, Issue 4, 2015, Pages 121-125

  Zhang, Xueyan ^a   He, Hairong ^a   Zheng, Xu ^a   Guo, Wenjie ^a   Wang, Yueqi ^a  

^a CHENGDU UNIVERSITY   (China)

Author keywords

Confidence intervals; RUNX3; Odds ratio; CI; OR; Runt related transcription factor 3

Indexed keywords

BISULFITE; TRANSCRIPTION FACTOR RUNX3; RUNX3 PROTEIN, HUMAN;

ARTICLE; CANCER RISK; DNA METHYLATION; HUMAN; LIVER CELL CARCINOMA; META ANALYSIS (TOPIC); POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION MAPPING; SENSITIVITY ANALYSIS; GENETICS; LIVER TUMOR; META ANALYSIS;

CARCINOMA, HEPATOCELLULAR; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DNA METHYLATION; HUMANS; LIVER NEOPLASMS; PROMOTER REGIONS, GENETIC;

EID: 84929996577     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2014.1003934     Document Type: Article

References (27)

1. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002;1:113-124.
2. Bae SC, Choi JK. Tumor suppressor activity of RUNX3. Oncogene 2004;24:4336-4340.
3. Lau QC, Raja E, Salto-Tellez M, Liu Q, Ito K, Inoue M, Putti TC, Loh M, Ko TK, Huang C, Bhalla KN, Zhu T, Ito Y, Sukumar S. RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Res 2006;13:6512-6520.
4. Jones PA. The DNA methylation paradox. Trends Genet 1999;1:34-37.
5. Xiao WH, Liu WW. Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma. World J Gastroenterol 2004;3:376-380.
6. Wei D, Gong W, Oh SC, Li Q, Kim WD, Wang L, Le X, Yao J, Wu TT, Huang S, Xie K. Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis. Cancer Res 2005;11:4809-4816.
7. Sato K, Tomizawa Y, Iijima H, Saito R, Ishizuka T, Nakajima T, Mori M. Epigenetic inactivation of the RUNX3 gene in lung cancer. Oncol Rep 2006;1:129-135.
8. Kim EJ, Kim YJ, Jeong P, Ha YS, Bae SC, KimWJ.Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor. J Urol 2008;3:1141-1145.
9. Hwang KT, Han W, Bae JY, Hwang SE, Shin HJ, Lee JE, Kim SW, Min HJ, Noh DY. Downregulation of the RUNX3 gene by promoter hypermethylation and hemizygous deletion in breast cancer. J Korean Med Sci 2007;S24-31.
10. Ku JL, Kang SB, Shin YK, Kang HC, Hong SH, Kim IJ, Shin JH, Han IO, Park JG. Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines. Oncogene 2004;40:6736-6742.
11. Gao F, Huang C, Lin M, Wang Z, Shen J, Zhang H, Jiang L, Chen Q. Frequent inactivation of RUNX3 by promoter hypermethylation and protein mislocalization in oral squamous cell carcinomas. J Cancer Res Clin Oncol 2009;5:739-747.
12. Tan SH, Ida H, Goh BC, Hsieh W, Loh M, Ito Y. Analyses of promoter hypermethylation for RUNX3 and other tumor suppressor genes in nasopharyngeal carcinoma. Anticancer Res 2006;6b:4287-4292.
13. Kim TY, Lee HJ, Hwang KS, Lee M, Kim JW, Bang YJ, Kang GH. Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab Invest 2004;4:479-484.
14. Xiao WH, Liu WW. [Improvement and application of methylation-specific polymerase chain reaction]. Ai Zheng 2004;11:1354-1356.
15. Mori T, Nomoto S, Koshikawa K, Fujii T, Sakai M, Nishikawa Y, Inoue S, Takeda S, Kaneko T, NakaoA.Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma. Liver Int 2005;2:380-388.
16. Park WS, Cho YG, Kim CJ, Song JH, Lee YS, Kim SY, Nam SW, Lee SH, Yoo NJ, Lee JY.Hypermethylation of the RUNX3 gene in hepatocellular carcinoma. Exp Mol Med 2005;4:276-281.
17. Miyagawa K, Sakakura C, Nakashima S, Yoshikawa T, Kin S, Nakase Y, Ito K, Yamagishi H, Ida H, Yazumi S, Chiba T, Ito Y, Hagiwara A. Down-regulation of RUNX1, RUNX3 and CBFbeta in hepatocellular carcinomas in an early stage of hepatocarcinogenesis. Anticancer Res 2006;5B:3633-3643.
18. Nomoto S, Kinoshita T, Kato K, Otani S, Kasuya H, Takeda S, Kanazumi N, Sugimoto H, Nakao A. Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma. Br J Cancer 2007;9:1260-1265.
19. Nishida N, Nagasaka T, Nishimura T, Ikai I, Boland CR, Goel A. Aberrant methylation ofmultiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma.Hepatology 2008;3:908-918.
20. Moribe T, Iizuka N, Miura T, Kimura N, Tamatsukuri S, Ishitsuka H, Hamamoto Y, Sakamoto K, Tamesa T, Oka M. Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma. Int J Cancer 2009;2:388-397.
21. Zhang HY, Liu J, Xie TB. Promoter hypermethylation of the RUNX3 gene in hepatocellular carcinoma. Acta Medicinae Universitatis Scientiae et Technologiae Huazhong 2009;1:23-26.
22. Hua D, Hu Y, Wu YY, Cheng ZH, Yu J, Du X, Huang ZH. Quantitative methylation analysis of multiple genes using methylation-sensitive restriction enzyme-based quantitative PCR for the detection of hepatocellular carcinoma. Exp Mol Pathol 2011;1:455-460.
23. Nishida N, Kudo M, Nagasaka T, Ikai I, Goel A. Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma. Hepatology 2012;3: 994-1003.
24. Dersimonian R, Laird N. Meta-Analysis in clinical trials. Control Clin Trials 1986;3:177-188.
25. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations inDNAmethylation: a fundamental aspect of neoplasia.Adv Cancer Res 1998;141-196.
26. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999;2:163-167.
27. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001;8:3225-3229.